One example of a primary resistance causing mechanism is that the upregulation of CXCL12 and FGF2 within the bone marrow microenvironment can shield AML blasts from FLT3 inhibitors [109,110]. This evidence concerns the gene CXCL12 and acute myeloid leukemia.